Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-130536
Filing Date
2023-05-01
Accepted
2023-05-01 16:31:02
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d502111d10ka.htm   iXBRL 10-K/A 349458
2 EX-31.3 d502111dex313.htm EX-31.3 4151
3 EX-31.4 d502111dex314.htm EX-31.4 4143
  Complete submission text file 0001193125-23-130536.txt   593682

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA surf-20221231.xsd EX-101.SCH 4982
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20221231_cal.xml EX-101.CAL 679
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20221231_def.xml EX-101.DEF 1684
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20221231_lab.xml EX-101.LAB 21946
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20221231_pre.xml EX-101.PRE 17115
10 EXTRACTED XBRL INSTANCE DOCUMENT d502111d10ka_htm.xml XML 8320
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38459 | Film No.: 23874213
SIC: 2836 Biological Products, (No Diagnostic Substances)